AIM：To detect the impact of insulin-like growth factor-1（IGF-1）and other risk factors for the early prediction of retinopathy of prematurity（ROP）and to establish a scoring system for ROP prediction by using clini...AIM：To detect the impact of insulin-like growth factor-1（IGF-1）and other risk factors for the early prediction of retinopathy of prematurity（ROP）and to establish a scoring system for ROP prediction by using clinical criteria and serum IGF-1 levels.METHODS：The study was conducted with 127 preterm infants.IGF-1 levels in the 1st day of life,1st,2nd,3rd and4th week of life was analyzed.The score was established after logistic regression analysis,considering the impact of each variable on the occurrences of any stage ROP.A validation cohort containing 107 preterm infants was included in the study and the predictive ability of ROP score was calculated.RESULTS：Birth weights（BW）,gestational weeks（GW）and the prevalence of breast milk consumption were lower,respiratory distress syndrome（RDS）,bronchopulmonarydysplasia（BPD）and necrotizing enterocolitis（NEC）were more frequent,the duration of mechanical ventilation and oxygen supplementation was longer in patients with ROP（P〈0.05）.Initial serum IGF-1 levels tended to be lower in newborns who developed ROP.Logistic regression analysis revealed that low BW（〈1250 g）,presence of intraventricular hemorrhage（IVH）and formula feeding increased the risk of ROP.Afterwards,the scoring system was validated on 107 infants.The negative predictive values of a score less than 4 were 84.3%,74.7%and 79.8%while positive predictive values were 76.3%,65.5%and71.6%respectively.CONCLUSION：In addition to BW〈1250 g and IVH,formula consumption was detected as a risk factor for the development of ROP.Breastfeeding is important for prevention of ROP in preterm infants.展开更多
OBJECTIVE: To study the value of serum insulin-like growth factor binding protein-3 (IGFBP-3) levels in differential diagnosis of growth hormone deficiency (GHD). METHODS: To measure serum IGFBP-3 levels by RIA in nor...OBJECTIVE: To study the value of serum insulin-like growth factor binding protein-3 (IGFBP-3) levels in differential diagnosis of growth hormone deficiency (GHD). METHODS: To measure serum IGFBP-3 levels by RIA in normal children and adolescents, GHD children and short-stature children without GHD. RESULTS: Serum level of IGFBP-3 in 129 children with untreated GHD and with no pubertal development was 1.6 +/- 0.9 mg/L, which was less than that in normal group of the same age, but overlapped with the normal children in Tanner stage I. After six-month treatment with recombinant human growth hormone (rhGH), serum level of IGFBP-3 in 59 GHD significantly increased from 1.3 +/- 0.7 mg/L to 2.7 +/- 0.9 mg/L, accompanied by an increase of body heights, growth velocities and serum level of IGF-1. Serum level of IGFBP-3 in 55 short-stature children without GHD was 3.3 +/- 2.2 mg/L, which was not significantly different from that in normal group. CONCLUSION: Serum IGFBP-3 level can reflect the status of GH secretion in children with GHD and is a useful marker for differential diagnosis of GHD.展开更多
In recent decades, due to the increasing risk of diabetes, the measurement and control of the blood sugar is of great importance. In typeI diabetes, because of the lack of insulin secretion, the cells cannot absorb gl...In recent decades, due to the increasing risk of diabetes, the measurement and control of the blood sugar is of great importance. In typeI diabetes, because of the lack of insulin secretion, the cells cannot absorb glucose, and thus have a low level of glucose. To control blood glucose, the insulin must be injected to the body. In fact, the injection must be in a completely controlled environment. If the level of the insulin exceeds the physiological limits, it may cause death. This paper presents an online approach to control the blood glucose level using a nonlinear model predictive control. This method, maintains the level of blood glucose concentration within a normal range. Thus, the blood glucose level is measured in each minute and predicted for the next time interval. If that is not in the normal range, amount of the insulin which must be injected will be determined. The proposed control approach includes important features such as model uncertainties and prevents acute decrease in the blood glucose level, and instability. In order to assess performance of the proposed controller, computer simulations have been carried out in Matlab/Simulink. Simulation results will reveal the effectiveness of the proposed nonlinear model predictive controller in adjusting the blood glucose level by injecting required insulin. So if the nutrition of the person decreases instantly, the hypoglycemia does not happen.展开更多
目的分析2型糖尿病患者血清肿瘤坏死因子受体相关因子3(TRAF3)的表达水平与胰岛功能和胰岛素抵抗(IR)的相关性。方法选取2022年8月至2023年12月收治的148例2型糖尿病患者,根据胰岛素抵抗指数(HOMA-IR)值分为无IR组75例和IR组73例;另选8...目的分析2型糖尿病患者血清肿瘤坏死因子受体相关因子3(TRAF3)的表达水平与胰岛功能和胰岛素抵抗(IR)的相关性。方法选取2022年8月至2023年12月收治的148例2型糖尿病患者,根据胰岛素抵抗指数(HOMA-IR)值分为无IR组75例和IR组73例;另选80例同期体检健康者作为对照组。酶联免疫吸附法测定血清TRAF3的表达水平;Pearson和Spearman法分析血清TRAF3表达水平与空腹胰岛素(FINS)、餐后2 h血糖(2 h PG)、胰岛β细胞功能指数(HOMA-β)、胰岛素敏感指数(ISI)相关性;多元线性回归分析2型糖尿病患者发生IR的影响因素;受试者工作特征(ROC)曲线分析血清TRAF3表达水平对2型糖尿病患者IR的预测价值。结果2型糖尿病患者血清TRAF3水平高于体检健康者,无IR组患者血清TRAF3水平低于IR组(P<0.01)。2型糖尿病患者无IR组和IR组FINS、三酰甘油、低密度脂蛋白胆固醇(LDL-C)、糖化血红蛋白(HbA1c)、空腹血糖(FPG)、2 h PG、HOMA-IR、HOMA-β、ISI比较差异有统计学意义(P<0.05,P<0.01);2型糖尿病患者血清TRAF3水平与FINS、2 h PG、HOMA-β、FPG呈显著正相关(P<0.05);多元线性回归分析结果显示,TRAF3、FINS、FPG、2 h PG、LDL-C、HbA1c均为2型糖尿病患者IR的影响因素(P<0.05,P<0.01);ROC曲线分析结果显示,血清TRAF3表达水平评估2型糖尿病患者IR的曲线下面积为0.818,敏感度和特异度分别为78.08%和73.00%。结论血清TRAF3表达水平与2型糖尿病患者胰岛功能和IR密切相关。展开更多
目的系统评价胰岛素不同给药方式对肠外营养患者血糖调控效果。方法计算机检索Cochrane、Embase、Medline、Web of Science、PubMed、中国知网(CNKI)和万方数据库中胰岛素不同给药方式在肠外营养患者中血糖调控效果的随机对照试验,检索...目的系统评价胰岛素不同给药方式对肠外营养患者血糖调控效果。方法计算机检索Cochrane、Embase、Medline、Web of Science、PubMed、中国知网(CNKI)和万方数据库中胰岛素不同给药方式在肠外营养患者中血糖调控效果的随机对照试验,检索时限为建库至2024年12月31日。使用RevMan 5.3和Stata 17.0进行数据分析。结果最终纳入17篇文献,共1017例患者,包括5种干预措施,分别是胰岛素加入肠外营养中、胰岛素静脉微泵法、胰岛素持续皮下注射、皮下注射甘精胰岛素、多次皮下注射胰岛素。meta分析结果显示:胰岛素静脉微泵法和胰岛素加入肠外营养中相比,胰岛素静脉微泵法控制血糖水平更佳,住院天数更少。累积排序概率图下面积显示:胰岛素静脉微泵法在血糖控制水平方面是最优干预措施。结论5种干预措施在控制血糖水平方面均有一定效果,在临床中应根据患者实际情况选择胰岛素给药方式,同时需样本量更大、多中心、前瞻性的随机对照试验,为肠外营养相关高血糖的优化治疗提供高质量的决策证据。展开更多
目的探究成人1型糖尿病(diabetes mellitus type 1,T1DM)患者应用胰岛素治疗中加入西格列汀的效果。方法目的选取2021年1月—2023年12月新沂市人民医院收治的76例成人T1DM患者作为研究对象。根据药物治疗方案不同分为对照组(胰岛素治疗...目的探究成人1型糖尿病(diabetes mellitus type 1,T1DM)患者应用胰岛素治疗中加入西格列汀的效果。方法目的选取2021年1月—2023年12月新沂市人民医院收治的76例成人T1DM患者作为研究对象。根据药物治疗方案不同分为对照组(胰岛素治疗)、观察组(胰岛素治疗基础上加入西格列汀),各38例。比较两组患者血糖水平、胰岛素用量及体重指数、不良反应发生率和低血糖发生率。结果治疗90 d后,观察组空腹血糖、餐后2 h血糖、糖化血红蛋白水平分别为(5.71±1.04)mmol/L、(8.61±1.86)mmol/L、(6.02±1.01)%,低于对照组的(6.22±1.06)mmol/L、(10.07±1.85)mmol/L、(6.55±1.22)%,差异均有统计学意义(t=2.117,3.431,2.063;P均<0.05)。治疗90 d后,观察组胰岛素用量更少,差异均有统计学意义(P均<0.05)。观察组和对照组体重指数、不良反应总发生率相比,差异均无统计学意义(P均>0.05),但观察组低血糖发生率低于对照组,差异有统计学意义(P<0.05)。结论胰岛素治疗成人T1DM基础上联用西格列汀,血糖水平控制效果显著,可减少胰岛素用量并降低低血糖发生风险且安全性良好。展开更多
文摘AIM：To detect the impact of insulin-like growth factor-1（IGF-1）and other risk factors for the early prediction of retinopathy of prematurity（ROP）and to establish a scoring system for ROP prediction by using clinical criteria and serum IGF-1 levels.METHODS：The study was conducted with 127 preterm infants.IGF-1 levels in the 1st day of life,1st,2nd,3rd and4th week of life was analyzed.The score was established after logistic regression analysis,considering the impact of each variable on the occurrences of any stage ROP.A validation cohort containing 107 preterm infants was included in the study and the predictive ability of ROP score was calculated.RESULTS：Birth weights（BW）,gestational weeks（GW）and the prevalence of breast milk consumption were lower,respiratory distress syndrome（RDS）,bronchopulmonarydysplasia（BPD）and necrotizing enterocolitis（NEC）were more frequent,the duration of mechanical ventilation and oxygen supplementation was longer in patients with ROP（P〈0.05）.Initial serum IGF-1 levels tended to be lower in newborns who developed ROP.Logistic regression analysis revealed that low BW（〈1250 g）,presence of intraventricular hemorrhage（IVH）and formula feeding increased the risk of ROP.Afterwards,the scoring system was validated on 107 infants.The negative predictive values of a score less than 4 were 84.3%,74.7%and 79.8%while positive predictive values were 76.3%,65.5%and71.6%respectively.CONCLUSION：In addition to BW〈1250 g and IVH,formula consumption was detected as a risk factor for the development of ROP.Breastfeeding is important for prevention of ROP in preterm infants.
文摘OBJECTIVE: To study the value of serum insulin-like growth factor binding protein-3 (IGFBP-3) levels in differential diagnosis of growth hormone deficiency (GHD). METHODS: To measure serum IGFBP-3 levels by RIA in normal children and adolescents, GHD children and short-stature children without GHD. RESULTS: Serum level of IGFBP-3 in 129 children with untreated GHD and with no pubertal development was 1.6 +/- 0.9 mg/L, which was less than that in normal group of the same age, but overlapped with the normal children in Tanner stage I. After six-month treatment with recombinant human growth hormone (rhGH), serum level of IGFBP-3 in 59 GHD significantly increased from 1.3 +/- 0.7 mg/L to 2.7 +/- 0.9 mg/L, accompanied by an increase of body heights, growth velocities and serum level of IGF-1. Serum level of IGFBP-3 in 55 short-stature children without GHD was 3.3 +/- 2.2 mg/L, which was not significantly different from that in normal group. CONCLUSION: Serum IGFBP-3 level can reflect the status of GH secretion in children with GHD and is a useful marker for differential diagnosis of GHD.
文摘In recent decades, due to the increasing risk of diabetes, the measurement and control of the blood sugar is of great importance. In typeI diabetes, because of the lack of insulin secretion, the cells cannot absorb glucose, and thus have a low level of glucose. To control blood glucose, the insulin must be injected to the body. In fact, the injection must be in a completely controlled environment. If the level of the insulin exceeds the physiological limits, it may cause death. This paper presents an online approach to control the blood glucose level using a nonlinear model predictive control. This method, maintains the level of blood glucose concentration within a normal range. Thus, the blood glucose level is measured in each minute and predicted for the next time interval. If that is not in the normal range, amount of the insulin which must be injected will be determined. The proposed control approach includes important features such as model uncertainties and prevents acute decrease in the blood glucose level, and instability. In order to assess performance of the proposed controller, computer simulations have been carried out in Matlab/Simulink. Simulation results will reveal the effectiveness of the proposed nonlinear model predictive controller in adjusting the blood glucose level by injecting required insulin. So if the nutrition of the person decreases instantly, the hypoglycemia does not happen.
文摘目的分析2型糖尿病患者血清肿瘤坏死因子受体相关因子3(TRAF3)的表达水平与胰岛功能和胰岛素抵抗(IR)的相关性。方法选取2022年8月至2023年12月收治的148例2型糖尿病患者,根据胰岛素抵抗指数(HOMA-IR)值分为无IR组75例和IR组73例;另选80例同期体检健康者作为对照组。酶联免疫吸附法测定血清TRAF3的表达水平;Pearson和Spearman法分析血清TRAF3表达水平与空腹胰岛素(FINS)、餐后2 h血糖(2 h PG)、胰岛β细胞功能指数(HOMA-β)、胰岛素敏感指数(ISI)相关性;多元线性回归分析2型糖尿病患者发生IR的影响因素;受试者工作特征(ROC)曲线分析血清TRAF3表达水平对2型糖尿病患者IR的预测价值。结果2型糖尿病患者血清TRAF3水平高于体检健康者,无IR组患者血清TRAF3水平低于IR组(P<0.01)。2型糖尿病患者无IR组和IR组FINS、三酰甘油、低密度脂蛋白胆固醇(LDL-C)、糖化血红蛋白(HbA1c)、空腹血糖(FPG)、2 h PG、HOMA-IR、HOMA-β、ISI比较差异有统计学意义(P<0.05,P<0.01);2型糖尿病患者血清TRAF3水平与FINS、2 h PG、HOMA-β、FPG呈显著正相关(P<0.05);多元线性回归分析结果显示,TRAF3、FINS、FPG、2 h PG、LDL-C、HbA1c均为2型糖尿病患者IR的影响因素(P<0.05,P<0.01);ROC曲线分析结果显示,血清TRAF3表达水平评估2型糖尿病患者IR的曲线下面积为0.818,敏感度和特异度分别为78.08%和73.00%。结论血清TRAF3表达水平与2型糖尿病患者胰岛功能和IR密切相关。
文摘目的系统评价胰岛素不同给药方式对肠外营养患者血糖调控效果。方法计算机检索Cochrane、Embase、Medline、Web of Science、PubMed、中国知网(CNKI)和万方数据库中胰岛素不同给药方式在肠外营养患者中血糖调控效果的随机对照试验,检索时限为建库至2024年12月31日。使用RevMan 5.3和Stata 17.0进行数据分析。结果最终纳入17篇文献,共1017例患者,包括5种干预措施,分别是胰岛素加入肠外营养中、胰岛素静脉微泵法、胰岛素持续皮下注射、皮下注射甘精胰岛素、多次皮下注射胰岛素。meta分析结果显示:胰岛素静脉微泵法和胰岛素加入肠外营养中相比,胰岛素静脉微泵法控制血糖水平更佳,住院天数更少。累积排序概率图下面积显示:胰岛素静脉微泵法在血糖控制水平方面是最优干预措施。结论5种干预措施在控制血糖水平方面均有一定效果,在临床中应根据患者实际情况选择胰岛素给药方式,同时需样本量更大、多中心、前瞻性的随机对照试验,为肠外营养相关高血糖的优化治疗提供高质量的决策证据。
